ZD-4009, a Novel BCL9 Inhibitor, Is Associated with Ameliorated Pulmonary Fibrosis and Reduced HIF-1α-Mediated Glycolysis and TGF-β/SMAD Signaling

2026/07/01 by Anqi Li, Yuanyuan Zhu, Fan Yang +16
Medicine · #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Lung Cancer Treatments and Mutations #Peptidase Inhibition and Analysis

paper · doi:10.1016/j.molpha.2026.100144

Citations

• New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein–protein interactions
• Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis